Is eribulin treatment prognostic factor in patients with metastatic breast cancer treated with this drug? Retrospective analysis of a multicentre study

Oruc, Zeynep; Kaplan, Muhammet; Geredeli, Caglayan; Sari, Nilgun; Ozaslan, Ersin; Aytekin, Aydin; ELKIRAN, EMİN; Koca, Sinan; Dogan, Mutlu; TURAN, NEDİM; Yuce, Ozlem; Sevinc, Alper; Ercelep, Ozlem; Isikdogan, Abdurrahman

Is eribulin treatment prognostic factor in patients with metastatic breast cancer treated with this drug? Retrospective analysis of a multicentre study

Copy For Citation

Oruc Z., Kaplan M. A. , Geredeli C., Sari N. Y. , Ozaslan E., Aytekin A., ...More

JOURNAL OF BUON, vol.24, no.5, pp.1876-1883, 2019 (Journal Indexed in SCI)

Publication Type: Article / Article
Volume: 24 Issue: 5
Publication Date: 2019
Title of Journal : JOURNAL OF BUON
Page Numbers: pp.1876-1883

Abstract

Purpose: This study aimed to analyze prognostic factors for survival and the reliability and the effectiveness of eribulin therapy in metastatic breast cancer (MBC) patients.